Genprex (GNPX) Change in Accured Expenses (2016 - 2026)

Genprex's Change in Accured Expenses history runs 11 years deep, the most recent figure standing at $266904.0 for Q1 2026.

• In Q1 2026, Change in Accured Expenses fell 40.87% year-over-year to $266904.0; the TTM figure through Mar 2026 stood at -$515711.0 (down 328.63% YoY), while the FY2025 annual figure was -$331226.0, up 22.38% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at $266904.0, up from -$876376.0 in the prior quarter.
• The five-year high for Change in Accured Expenses was $799453.0 in Q2 2023, with the low at -$1.2 million in Q4 2023.
• The 5-year median for Change in Accured Expenses is $266904.0 (2026), against an average of $44320.7.
• The sharpest annual moves came in 2022 and 2023: Change in Accured Expenses soared 1807.72% in 2022, then sank 309.97% in 2023.
• Genprex's Change in Accured Expenses stood at $593921.0 in 2022, then tumbled by 309.97% to -$1.2 million in 2023, then surged by 139.43% to $491704.0 in 2024, then tumbled by 278.23% to -$876376.0 in 2025, then jumped by 130.46% to $266904.0 in 2026.
• Business Quant data shows GNPX's Change in Accured Expenses at $266904.0 in Q1 2026, -$876376.0 in Q4 2025, and $469509.0 in Q3 2025.